L. Masana

31.3k total citations · 3 hit papers
376 papers, 10.0k citations indexed

About

L. Masana is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Masana has authored 376 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Surgery, 117 papers in Endocrinology, Diabetes and Metabolism and 97 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Masana's work include Lipoproteins and Cardiovascular Health (149 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (100 papers) and Peroxisome Proliferator-Activated Receptors (45 papers). L. Masana is often cited by papers focused on Lipoproteins and Cardiovascular Health (149 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (100 papers) and Peroxisome Proliferator-Activated Receptors (45 papers). L. Masana collaborates with scholars based in Spain, Italy and United States. L. Masana's co-authors include Núria Plana, Josefa Girona, Mercedes Heras, Josep Ribalta, Anna Cabré, Joan-Carles Vallvé, Jorge Joven, Lâle Tokgözoğlu, Kausik K. Ray and Daiana Ibarretxe and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

L. Masana

357 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipoprotein(a) as a cardiovascular risk factor: current status

2010 1.3k citations Kausik K. Ray, Petri T. Kovanen et al. European Heart Journal profile →
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

2011 887 citations Petri T. Kovanen, L. Masana et al. European Heart Journal profile →
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

2025 16 citations Francesco Barbagallo, Daiana Ibarretxe et al. Cardiovascular Diabetology profile →

Peers

Countries citing papers authored by L. Masana

Since Specialization

Citations

This map shows the geographic impact of L. Masana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Masana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Masana more than expected).

Fields of papers citing papers by L. Masana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Masana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Masana. The network helps show where L. Masana may publish in the future.

Co-authorship network of co-authors of L. Masana

This figure shows the co-authorship network connecting the top 25 collaborators of L. Masana. A scholar is included among the top collaborators of L. Masana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Masana. L. Masana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study 2025 ·Biomolecules ·Marta Tajes, (unknown), Josefa Girona, (unknown), Montse Guardiola, José Manuel García‐Pinilla, Josep Ribalta, Marta Cobo Marcos, L. Masana, Javier de Juan Bagudá, Cândida Fonseca, Cristina Enjuanes, Manuel Vázquez‐Carrera, Josep Comín‐Colet, Ricardo Rodríguez‐Calvo	0
2	Advancing atherosclerosis research: The Power of lipid imaging with MALDI-MSI 2025 ·Atherosclerosis ·(unknown), (unknown), L. Masana, Paolo Magni, Óscar Yanes, María Vinaixa	1
3	Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice 2024 ·Clínica e Investigación en Arteriosclerosis (English Edition) ·Javier Delgado‐Lista, José María Mostaza, (unknown), Francisco Blanco‐Vaca, L. Masana, Juan Pedro‐Botet, Pablo Pérez‐Martínez, Fernando Civeira, (unknown), José Javier Gómez-Barrado, Carlos Lahoz, Xavier Pintó, (unknown), José López‐Miranda, Carlos Guijarro	0
4	PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia 2024 ·JACC Basic to Translational Science ·(unknown), Marina Canyelles, Josefa Girona, Daiana Ibarretxe, David Santos, (unknown), Vicenta Llorente‐Cortés, Noemí Rotllán, Petri T. Kovanen, Matti Jauhiainen, Miriam Lee‐Rueckert, L. Masana, Francisco Arrieta, Javier Martı́nez-Botas, Diego Gómez‐Coronado, Josep Ribalta, Mireia Tondo, Francisco Blanco‐Vaca, Joan Carles Escolà‐Gil	1
5	Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes 2024 ·Cardiovascular Diabetology ·(unknown), Rosa M. Sánchez-Hernández, Núria Plana, Daiana Ibarretxe, (unknown), Josep Ribalta, (unknown), Ana M. Wägner, L. Masana, Mauro Boronat	6
6	Lipidomics Reveals Myocardial Lipid Composition in a Murine Model of Insulin Resistance Induced by a High-Fat Diet 2024 ·International Journal of Molecular Sciences ·Josefa Girona, (unknown), Sara Samino, Alexandra Junza, Neus Martínez-Micaelo, María García‐Altares, Pere Ràfols, Yaiza Esteban, Óscar Yanes, Xavier Correig, L. Masana, Ricardo Rodríguez‐Calvo	2
7	Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 2024 ·European Journal of Internal Medicine ·(unknown), Francesco Barbagallo, (unknown), (unknown), (unknown), (unknown), (unknown), Stefania Di Mauro, Agnese Filippello, Alessandra Scamporrino, Antonino Di Pino, L. Masana, Francesco Purrello, Salvatore Piro, Roberto Scicali	14
8	WITHDRAWN: Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice 2024 ·Clínica e Investigación en Arteriosclerosis (English Edition) ·Javier Delgado‐Lista, José María Mostaza, (unknown), Francisco Blanco‐Vaca, L. Masana, Juan Pedro‐Botet, Pablo Pérez‐Martínez, Fernando Civeira, (unknown), José Javier Gómez-Barrado, Carlos Lahoz, Xavier Pintó, (unknown), José López‐Miranda, Carlos Guijarro	0
9	Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study 2023 ·SHILAP Revista de lepidopterología ·L. Masana, Alberto Zambon, Claus Peter Schmitt, Christina Taylan, (unknown), Hofit Cohen, Paola Sabrina Buonuomo, (unknown), (unknown), José Luis Díaz-Díaz, Faouzi Maatouk, Sergio Martínez‐Hervás, Brian Mangal, (unknown), Thomas F. Cunningham	1
10	PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 2023 ·International Journal of Molecular Sciences ·(unknown), Josefa Girona, Montse Guardiola, Núria Plana, Roberto Scicali, Salvatore Piro, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Lluís Recasens, (unknown), Roser Rosales, Yaiza Esteban, Núria Amigó, L. Masana, Daiana Ibarretxe, Josep Ribalta	7
11	Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study 2023 ·ClinicoEconomics and Outcomes Research ·Alberto Cordero, Regina Dalmau, L. Masana, Valentı́n Fuster, (unknown), (unknown), (unknown), Antoni Sicras‐Mainar, José Ramón González‐Juanatey	3
12	Lipidomics of triglyceride‐rich lipoproteins derived from hyperlipidemic patients on inflammation 2023 ·European Journal of Clinical Investigation ·(unknown), (unknown), Ricardo Rodríguez‐Calvo, Núria Plana, Núria Amigó, Roser Rosales, Yaiza Esteban, L. Masana, Daiana Ibarretxe, Josefa Girona	8
13	Glycoprotein and Lipoprotein Profiles Assessed by 1H-NMR and Its Relation to Ascending Aortic Dilatation in Bicuspid Aortic Valve Disease 2022 ·Journal of Clinical Medicine ·(unknown), (unknown), Neus Martínez-Micaelo, Laura Galián-Gay, (unknown), (unknown), L. Masana, Núria Amigó, Arturo Evangelista, Josep M. Alegret	1
14	Combination lipid-lowering therapy as first-line strategy in very high-risk patients 2021 ·European Heart Journal ·Kausik K. Ray, Laurens F. Reeskamp, Ulrich Laufs, Maciej Banach, François Mach, Lâle Tokgözoğlu, Derek Connolly, Anja J. Gerrits, Erik S.G. Stroes, L. Masana, John J.P. Kastelein	123
15	Actualización de las tablas de planificación terapéutica hipocolesterolemiante orientadas a la obtención de los objetivos terapéuticos 2019 ·Clínica e Investigación en Arteriosclerosis ·L. Masana, Núria Plana	8
16	Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype 2019 ·Atherosclerosis ·Rafel Ramos, L. Masana, Marc Comas‐Cufí, Maria García-Gil, Ruth Martí‐Lluch, Anna Ponjoan, Núria Plana, Lia Alves‐Cabratosa, Jaume Marrugat, Roberto Elosúa, Irene R. Dégano, (unknown), Alberto Zamora	5
17	Increasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate–high cardiovascular risk 2014 ·The Journal of Nutritional Biochemistry ·Jordi Merino, Aleix Sala‐Vila, Richard Kones, Raimón Ferré, Núria Plana, Josefa Girona, Daiana Ibarretxe, Mercedes Heras, Emilio Ros, L. Masana	19
18	Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease 2003 ·Current Opinion in Clinical Nutrition & Metabolic Care ·Josep Ribalta, Joan-Carles Vallvé, Josefa Girona, L. Masana	52
19	Norte y sur 1999 ·Medicina Clínica ·L. Masana	0
20	Hépatite granulomateuse: étude étiologique de 107 cas. 1978 ·La Nouvelle presse médicale ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), L. Masana, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact